Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-06-28 Purchase | 2021-06-29 4:16 pm | Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale SVP, General Counsel | 1,088 | $9.01 | $9,803 | 1,088 (Direct) | View |
| 2019-02-05 Sale | 2019-02-07 4:30 pm | ARRAY BIOPHARMA INC | ARRY | Oltmans Curtis Gale General Counsel | 40,000 | $20 | $800,000 | 378,921 (Direct) | View |
| 2019-01-25 Sale | 2019-01-29 4:27 pm | ARRAY BIOPHARMA INC | ARRY | Oltmans Curtis Gale General Counsel | 14,029 | $18 | $252,523 | 822,821 (Direct) | View |
| 2019-01-18 Sale | 2019-01-23 4:47 pm | ARRAY BIOPHARMA INC | ARRY | Oltmans Curtis Gale General Counsel | 1,251 | $18 | $22,518 | 432,950 (Direct) | View |
| 2019-01-15 Sale | 2019-01-17 4:58 pm | ARRAY BIOPHARMA INC | ARRY | Oltmans Curtis Gale General Counsel | 19,720 | $18.06 | $356,139 | 434,201 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-02-09 Option Award | 2023-02-13 4:15 pm | N/A 2033-02-08 | Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale Chief Legal Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2022-08-09 Option Award | 2022-08-11 4:15 pm | N/A 2032-08-08 | Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale Chief Legal Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-01-19 Option Award | 2022-01-21 4:15 pm | N/A 2032-01-18 | Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale SVP, General Counsel | 60,000 | $0 | 60,000 (Direct) | View |
| 2021-12-17 Ownership | 2022-01-07 4:15 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale SVP, General Counsel | 1,088 | $0 | 1,248 (Direct) | View |
| 2021-12-17 Option Award | 2021-12-21 4:24 pm | N/A N/A | AVENUE THERAPEUTICS INC. | ATXI | Oltmans Curtis Gale Director | 49,020 | $0 | 49,020 (Direct) | View |
| 2020-12-03 Option Award | 2020-12-07 4:30 pm | N/A 2030-12-02 | Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale SVP, General Counsel | 153,600 | $0 | 153,600 (Direct) | View |
Ownership | 2020-12-07 4:15 pm | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale SVP, General Counsel | 0 | $0 | 0 (Direct) | View |
| 2019-01-29 Exercise | 2019-02-07 4:30 pm | N/A N/A | ARRAY BIOPHARMA INC | ARRY | Oltmans Curtis Gale General Counsel | 51,100 | $8.94 | 378,921 (Direct) | View |
| 2019-02-05 Exercise | 2019-02-07 4:30 pm | N/A 2027-08-15 | ARRAY BIOPHARMA INC | ARRY | Oltmans Curtis Gale General Counsel | 40,000 | $0 | 378,921 (Direct) | View |
| 2019-01-25 Exercise | 2019-01-29 4:27 pm | N/A N/A | ARRAY BIOPHARMA INC | ARRY | Oltmans Curtis Gale General Counsel | 14,029 | $8.94 | 822,821 (Direct) | View |
| 2019-01-25 Exercise | 2019-01-29 4:27 pm | N/A 2027-08-15 | ARRAY BIOPHARMA INC | ARRY | Oltmans Curtis Gale General Counsel | 25,129 | $0 | 822,821 (Direct) | View |
| 2019-01-18 Exercise | 2019-01-23 4:47 pm | N/A N/A | ARRAY BIOPHARMA INC | ARRY | Oltmans Curtis Gale General Counsel | 1,251 | $8.94 | 432,950 (Direct) | View |
| 2019-01-18 Exercise | 2019-01-23 4:47 pm | N/A 2027-08-15 | ARRAY BIOPHARMA INC | ARRY | Oltmans Curtis Gale General Counsel | 1,251 | $0 | 432,950 (Direct) | View |
| 2019-01-15 Exercise | 2019-01-17 4:58 pm | N/A N/A | ARRAY BIOPHARMA INC | ARRY | Oltmans Curtis Gale General Counsel | 19,720 | $8.94 | 434,201 (Direct) | View |
| 2019-01-15 Exercise | 2019-01-17 4:58 pm | N/A 2027-08-15 | ARRAY BIOPHARMA INC | ARRY | Oltmans Curtis Gale General Counsel | 19,720 | $0 | 434,201 (Direct) | View |
| 2018-12-16 Tax Withholding | 2018-12-18 7:48 pm | N/A N/A | ARRAY BIOPHARMA INC | ARRY | Oltmans Curtis Gale General Counsel | 3,079 | $15.97 | 160,546 (Direct) | View |
| 2018-12-16 Exercise | 2018-12-18 7:48 pm | N/A 2021-12-17 | ARRAY BIOPHARMA INC | ARRY | Oltmans Curtis Gale General Counsel | 7,000 | $0 | 160,546 (Direct) | View |
| 2018-12-14 Option Award | 2018-12-18 7:48 pm | N/A 2022-12-20 | ARRAY BIOPHARMA INC | ARRY | Oltmans Curtis Gale General Counsel | 135,625 | $0 | 160,546 (Direct) | View |